BRIEF-Ligand enters into worldwide omniab platform license agreement with Xcella Biosciences

* Ligand enters into worldwide omniab® platform license agreement with xcella biosciences
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.